A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

著者: Sumanta K. Pal, Catherine M. Tangen, Ian M. Thompson, Naomi Balzer-Haas, Daniel J. George, Daniel Y.C. Heng, Brian Shuch, Mark N. Stein, Maria Tretiakova, Peter A. Humphrey, Adebowale Adeniran, Vivek Narayan, Georg A. Bjarnason, Ulka N. Vaishampayan, Ajjai Alva, Tian Zhang, Scott Cole, Melissa Plets, John Wright, Primo N. Lara - The Lancet 2021 被引用: 279